Menu
Home
Forums
Forums

Quick Links
- Search Forums
- Recent Posts
job listings
catering
whistleblower info
legal help
advertise on CP
submit press release
Menu

Log in
Sign up
Search titles only

Posted by Member:

Separate names with a comma.

Newer Than:

Search this thread only

Search this forum only

Display results as threads

More...

Useful Searches

Recent Posts

Abbott CEO on Libre: ‘We’re just getting started’

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Oct 18, 2018 at 11:42 AM.

#1 cafead, Oct 18, 2018 at 11:42 AM

cafead Administrator
Staff Member

Joined:

Nov 21, 2001

Messages:

33,028

Likes Received:

3

via The company’s diabetes revenues grew 37.5% to $512 million in Q3. Abbott touted a number of regulatory wins for its FreeStyle Libre sensor-based continuous glucose monitoring system, including FDA approval of the 14-day system and CE Mark for its Libre 2 system.

article source

Quote

Reply to Thread